Longeveron LGVN
NASDAQ LGVN
$3.30 +0.46 (+16.20%)
At close: Nov 11, 2026 · 4:00 PM EST

Longeveron (LGVN) EBITDA Margin (2020 - 2026)

Updated

Longeveron (LGVN) recorded EBITDA Margin of -2073.17% in Q2 2026, down 448.49 percentage points from -1624.68% a year earlier and down 936.74 percentage points from the prior quarter.

Analysis

Longeveron (LGVN) EBITDA Margin (2020 - 2026) Analysis & Trends

On a TTM basis, Longeveron's EBITDA Margin came in at -1907.33% as of Jun 30, 2026, down 1022.28 percentage points year-over-year; for FY2025, it came in at -1839.95%, down 1189.28 percentage points from FY2024.

  • Annual EBITDA Margin has a five-year change of -1786.78 percentage points (FY2020 to FY2025).
  • Across earlier years, EBITDA Margin came in at -650.67% in FY2024 (+2181.91 pp), -2832.58% in FY2023 (-1429.14 pp), -1403.44% in FY2022 (-136.82 pp) and -1266.62% in FY2021 (-1213.44 pp).
  • Quarterly EBITDA Margin has ranged from -8260.32% in Q4 2023 to -571.02% in Q3 2024 over the past five years.
  • On a year-over-year basis, EBITDA Margin rose in three of the last eight quarters, with an average year-over-year change of +398.74 percentage points.
  • Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 7590.50 percentage points in Q4 2024, against a drop of 4572.04 percentage points in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -1136.43% (Q1 2026), -1403.01% (Q4 2025) and -5143.07% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 36.69%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 32.68%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 46.88%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 40.60%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 39.77%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 46.62%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 50.63%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 42.49%
10 Longeveron 8.60 Mn -31.21 Mn 182,000.00 -2,073.17%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,073.17%
Mar 31, 2026 -1,136.43%
Dec 31, 2025 -1,403.01%
Sep 30, 2025 -5,143.07%
Jun 30, 2025 -1,624.68%
Mar 31, 2025 -1,249.34%
Dec 31, 2024 -669.82%
Sep 30, 2024 -571.02%
Jun 30, 2024 -698.93%
Mar 31, 2024 -700.36%
Dec 31, 2023 -8,260.32%
Sep 30, 2023 -3,286.00%
Jun 30, 2023 -2,521.66%
Mar 31, 2023 -1,605.02%
Dec 31, 2022 -4,136.36%
Sep 30, 2022 -1,866.79%
Jun 30, 2022 -856.65%
Mar 31, 2022 -866.49%
Dec 31, 2021 -1,818.18%
Sep 30, 2021 -2,012.50%
API Access

Longeveron EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LGVN&period=max&api_key=YOUR_API_KEY